Related Experiment Video
Updated: Oct 24, 2025

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
Identify Inflammatory Bowel Disease-Related Genes Based on Machine Learning.
Lili Ye1, Yongwei Lin2, Xing-di Fan2
1Daycare Chemotherapy Center, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
This study identifies genes linked to Inflammatory Bowel Disease (IBD) by analyzing disease similarities and gene interactions. A Support Vector Machine (SVM) method effectively predicted IBD-related genes, aiding in understanding this complex condition.
Area of Science:
- Genetics and Bioinformatics
- Gastroenterology
- Computational Biology
Background:
- Inflammatory Bowel Disease (IBD) is a growing global health concern, characterized by chronicity and association with colorectal cancer (CRC).
- Genetic factors are strongly implicated in IBD pathogenesis, necessitating the identification of IBD-related genes.
- Understanding IBD-related genes is crucial for developing effective diagnostic and therapeutic strategies.
Purpose of the Study:
- To identify novel genes associated with Inflammatory Bowel Disease (IBD) using a computational approach.
- To leverage disease similarities and gene interaction networks for gene discovery.
- To develop and validate a machine learning model for predicting IBD-related genes.
Main Methods:
- A Support Vector Machine (SVM)-based method was employed, integrating disease similarity information and gene interaction data.
- Candidate IBD-related genes were identified by analyzing 135 diseases with similarities to IBD.
- Gene features were extracted, and SVM was trained to predict the probability of a gene being IBD-related, with ten-cross validation used for performance assessment.
Main Results:
- The SVM-based method achieved high performance, with an Area Under the Curve (AUC) of 0.93 and an Area Under the Precision-Recall Curve (AUPR) of 0.97.
- This predictive accuracy surpassed that of three other evaluated methods.
- Top candidate genes were prioritized, and case studies were conducted on the five most significant genes.
Conclusions:
- The developed SVM-based method is effective and accurate for identifying IBD-related genes.
- This approach offers a valuable tool for gene discovery in complex diseases like IBD.
- The findings contribute to a better understanding of the genetic underpinnings of IBD and its link to CRC.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

